Acro Biomedical Co, LTD 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink

8 Jan 2026

ACBM

Acro Biomedical Co, LTD

8-K: Acro Biomedical Changes Auditor Amid Going Concern Warning

Acro Biomedical Co., Ltd. announced a change in its independent registered public accounting firm, dismissing KCCW Accountancy Corp. and engaging Weinberg & Company, while KCCW's prior reports included a going concern explanatory paragraph.

OTC.Pink

14 Aug 2025

ACBM

Acro Biomedical Co, LTD

8-K: ACRO Biomedical Appoints Yu-Ting Su as New CEO

ACRO Biomedical Co., Ltd. announced the resignation of Pao-Chi Chu as director, chairman, and chief executive officer, appointing Yu-Ting Su to succeed him, effective August 14, 2025.

OTC.Pink

2 Jul 2025

ACBM

Acro Biomedical Co, LTD

8-K: Acro Biomedical Changes Auditors Amidst Going Concern Note

Acro Biomedical Co., Ltd. has appointed KCCW Accountancy Corp. as its new independent registered public accounting firm, replacing Prager Metis CPAs, LLC.